Cargando…

Adherence to Combination Antiretroviral Therapy among Pregnant Women Enrolled in a HIV Prevention Program in Rural North-central Nigeria

OBJECTIVE: Adherence to combination antiretroviral therapy (ART) among pregnant women is essential to attaining the goal of eliminating mother-to-child HIV transmission. The objective of this study was to determine which factors affect adherence to ART among HIV-positive women enrolled in a large pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Calder, Cedrina L., O’Hara, Heather, Tabatabai, Mohammad, Maxwell, Celia J., Marryshow, Salisha, Ahonkhai, Aima A., Audet, Carolyn M., Wester, C. William, Aliyu, Muktar H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Global Health and Education Projects, Inc 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031888/
https://www.ncbi.nlm.nih.gov/pubmed/32123632
http://dx.doi.org/10.21106/ijma.327
_version_ 1783499462046384128
author Calder, Cedrina L.
O’Hara, Heather
Tabatabai, Mohammad
Maxwell, Celia J.
Marryshow, Salisha
Ahonkhai, Aima A.
Audet, Carolyn M.
Wester, C. William
Aliyu, Muktar H.
author_facet Calder, Cedrina L.
O’Hara, Heather
Tabatabai, Mohammad
Maxwell, Celia J.
Marryshow, Salisha
Ahonkhai, Aima A.
Audet, Carolyn M.
Wester, C. William
Aliyu, Muktar H.
author_sort Calder, Cedrina L.
collection PubMed
description OBJECTIVE: Adherence to combination antiretroviral therapy (ART) among pregnant women is essential to attaining the goal of eliminating mother-to-child HIV transmission. The objective of this study was to determine which factors affect adherence to ART among HIV-positive women enrolled in a large prevention of mother-to-child HIV transmission (PMTCT) trial in rural north-central Nigeria. METHODS: The parent study included 372 HIV-positive pregnant women enrolled in a cluster-randomized control trial conducted at 12 health facilities in Nigeria between 2013 and 2015. This secondary analysis included HIV-positive women (and their infants) from the original trial with documented adherence data (n=210, 56.5%). The primary outcome was maternal adherence to ART, determined by self-report and based on the visual analogue scale (VAS) of a validated medication adherence tool. Participants with a VAS score of ≥ 95% were classified as adherent. We employed multivariate logistic regression to evaluate the predictors of maternal ART adherence in the study sample. RESULTS: Approximately 61.0% of study participants (128/210) were adherent to ART. The majority of adherent participants (62.5%, 80/128) were enrolled in the trial intervention arm. The most common cited response for non-adherence was fear of status disclosure. Adherence to ART was associated with study arm (intervention arm vs. control arm, adjusted Odds Ratio (aOR) [95% CI]: 16.95 [5.30-54.23]), maternal ethnicity (Gwari vs. Other, aOR = 0.13 [0.05-0.38]), and partner HIV status (HIV-positive vs. unknown, aOR = 3.14 [1.22-8.07]). CONCLUSION AND GLOBAL HEALTH IMPLICATIONS: Adherence to ART among a cohort of pregnant women enrolled in a PMTCT trial in rural North-Central Nigeria was associated with trial arm, maternal self-reported ethnicity, and partner’s HIV status. Increased understanding of the interplay between these factors will enable the development of more targeted and effective interventions.
format Online
Article
Text
id pubmed-7031888
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Global Health and Education Projects, Inc
record_format MEDLINE/PubMed
spelling pubmed-70318882020-03-02 Adherence to Combination Antiretroviral Therapy among Pregnant Women Enrolled in a HIV Prevention Program in Rural North-central Nigeria Calder, Cedrina L. O’Hara, Heather Tabatabai, Mohammad Maxwell, Celia J. Marryshow, Salisha Ahonkhai, Aima A. Audet, Carolyn M. Wester, C. William Aliyu, Muktar H. Int J MCH AIDS Original Article OBJECTIVE: Adherence to combination antiretroviral therapy (ART) among pregnant women is essential to attaining the goal of eliminating mother-to-child HIV transmission. The objective of this study was to determine which factors affect adherence to ART among HIV-positive women enrolled in a large prevention of mother-to-child HIV transmission (PMTCT) trial in rural north-central Nigeria. METHODS: The parent study included 372 HIV-positive pregnant women enrolled in a cluster-randomized control trial conducted at 12 health facilities in Nigeria between 2013 and 2015. This secondary analysis included HIV-positive women (and their infants) from the original trial with documented adherence data (n=210, 56.5%). The primary outcome was maternal adherence to ART, determined by self-report and based on the visual analogue scale (VAS) of a validated medication adherence tool. Participants with a VAS score of ≥ 95% were classified as adherent. We employed multivariate logistic regression to evaluate the predictors of maternal ART adherence in the study sample. RESULTS: Approximately 61.0% of study participants (128/210) were adherent to ART. The majority of adherent participants (62.5%, 80/128) were enrolled in the trial intervention arm. The most common cited response for non-adherence was fear of status disclosure. Adherence to ART was associated with study arm (intervention arm vs. control arm, adjusted Odds Ratio (aOR) [95% CI]: 16.95 [5.30-54.23]), maternal ethnicity (Gwari vs. Other, aOR = 0.13 [0.05-0.38]), and partner HIV status (HIV-positive vs. unknown, aOR = 3.14 [1.22-8.07]). CONCLUSION AND GLOBAL HEALTH IMPLICATIONS: Adherence to ART among a cohort of pregnant women enrolled in a PMTCT trial in rural North-Central Nigeria was associated with trial arm, maternal self-reported ethnicity, and partner’s HIV status. Increased understanding of the interplay between these factors will enable the development of more targeted and effective interventions. Global Health and Education Projects, Inc 2020 2020-01-12 /pmc/articles/PMC7031888/ /pubmed/32123632 http://dx.doi.org/10.21106/ijma.327 Text en Copyright © 2020 Calder et al. http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Calder, Cedrina L.
O’Hara, Heather
Tabatabai, Mohammad
Maxwell, Celia J.
Marryshow, Salisha
Ahonkhai, Aima A.
Audet, Carolyn M.
Wester, C. William
Aliyu, Muktar H.
Adherence to Combination Antiretroviral Therapy among Pregnant Women Enrolled in a HIV Prevention Program in Rural North-central Nigeria
title Adherence to Combination Antiretroviral Therapy among Pregnant Women Enrolled in a HIV Prevention Program in Rural North-central Nigeria
title_full Adherence to Combination Antiretroviral Therapy among Pregnant Women Enrolled in a HIV Prevention Program in Rural North-central Nigeria
title_fullStr Adherence to Combination Antiretroviral Therapy among Pregnant Women Enrolled in a HIV Prevention Program in Rural North-central Nigeria
title_full_unstemmed Adherence to Combination Antiretroviral Therapy among Pregnant Women Enrolled in a HIV Prevention Program in Rural North-central Nigeria
title_short Adherence to Combination Antiretroviral Therapy among Pregnant Women Enrolled in a HIV Prevention Program in Rural North-central Nigeria
title_sort adherence to combination antiretroviral therapy among pregnant women enrolled in a hiv prevention program in rural north-central nigeria
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031888/
https://www.ncbi.nlm.nih.gov/pubmed/32123632
http://dx.doi.org/10.21106/ijma.327
work_keys_str_mv AT caldercedrinal adherencetocombinationantiretroviraltherapyamongpregnantwomenenrolledinahivpreventionprograminruralnorthcentralnigeria
AT oharaheather adherencetocombinationantiretroviraltherapyamongpregnantwomenenrolledinahivpreventionprograminruralnorthcentralnigeria
AT tabatabaimohammad adherencetocombinationantiretroviraltherapyamongpregnantwomenenrolledinahivpreventionprograminruralnorthcentralnigeria
AT maxwellceliaj adherencetocombinationantiretroviraltherapyamongpregnantwomenenrolledinahivpreventionprograminruralnorthcentralnigeria
AT marryshowsalisha adherencetocombinationantiretroviraltherapyamongpregnantwomenenrolledinahivpreventionprograminruralnorthcentralnigeria
AT ahonkhaiaimaa adherencetocombinationantiretroviraltherapyamongpregnantwomenenrolledinahivpreventionprograminruralnorthcentralnigeria
AT audetcarolynm adherencetocombinationantiretroviraltherapyamongpregnantwomenenrolledinahivpreventionprograminruralnorthcentralnigeria
AT westercwilliam adherencetocombinationantiretroviraltherapyamongpregnantwomenenrolledinahivpreventionprograminruralnorthcentralnigeria
AT aliyumuktarh adherencetocombinationantiretroviraltherapyamongpregnantwomenenrolledinahivpreventionprograminruralnorthcentralnigeria